Pool W F, Crooks P A
Division of Medicinal Chemistry, University of Kentucky, Lexington 40536-0053.
J Pharm Pharmacol. 1988 Nov;40(11):758-62. doi: 10.1111/j.2042-7158.1988.tb05167.x.
The in-vivo metabolism of R-(+)-[3H-N'-CH3; 14C-N-CH3]-N-methylnicotinium acetate (NMN) was studied in the guinea-pig to determine the in-vivo stability of the N-methyl and N'-methyl groups of this primary nicotine metabolite. The results showed that N-demethylation does not occur. However, losses of 34 and 36%, respectively, of the 3H label in the N'-CH3 group of urinary NMN and the secondary metabolite, N-methyl-N'-oxonicotinium ion (NMNO), were observed. These results suggest that biotransformation of NMN may involve either an initial N'-demethylation step to N-methylnornicotinium ion (NMNor) followed by N'-methylation back to NMN, or the formation of an N'-methylene iminium species, which may be reductively converted back to NMN.
在豚鼠体内研究了R-(+)-[3H-N'-CH3; 14C-N-CH3]-N-甲基烟碱乙酸盐(NMN)的体内代谢,以确定这种主要尼古丁代谢物的N-甲基和N'-甲基基团在体内的稳定性。结果表明未发生N-去甲基化。然而,观察到尿中NMN的N'-CH3基团和次要代谢物N-甲基-N'-氧代烟碱离子(NMNO)中3H标记分别损失了34%和36%。这些结果表明,NMN的生物转化可能涉及一个初始的N'-去甲基化步骤生成N-甲基去甲烟碱离子(NMNor),随后再进行N'-甲基化变回NMN,或者形成一种N'-亚甲基亚胺物种,该物种可能被还原转化回NMN。